A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Phase of Trial: Phase IV
Latest Information Update: 11 Apr 2017
At a glance
- Drugs Efinaconazole (Primary)
- Indications Onychomycosis
- Focus Adverse reactions
- Sponsors Valeant Pharmaceuticals International
- 05 Apr 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 21 Sep 2016 Status changed from not yet recruiting to recruiting.
- 22 Jul 2016 New trial record